GASTALDI, SIMONE
 Distribuzione geografica
Continente #
EU - Europa 933
AS - Asia 881
NA - Nord America 847
AF - Africa 70
OC - Oceania 37
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.791
Nazione #
US - Stati Uniti d'America 806
CN - Cina 424
IT - Italia 306
GB - Regno Unito 141
IN - India 132
DE - Germania 112
CZ - Repubblica Ceca 68
FR - Francia 60
JP - Giappone 56
RU - Federazione Russa 47
NL - Olanda 39
HK - Hong Kong 36
KR - Corea 32
AU - Australia 30
CA - Canada 30
EG - Egitto 29
IR - Iran 28
VN - Vietnam 26
TR - Turchia 25
UA - Ucraina 22
CH - Svizzera 18
TW - Taiwan 18
UZ - Uzbekistan 18
ID - Indonesia 15
ES - Italia 14
BE - Belgio 13
BR - Brasile 13
MY - Malesia 12
RO - Romania 12
SE - Svezia 11
IE - Irlanda 10
MX - Messico 9
PH - Filippine 9
SG - Singapore 9
AT - Austria 8
IL - Israele 8
IQ - Iraq 8
MA - Marocco 8
MK - Macedonia 8
NZ - Nuova Zelanda 7
PK - Pakistan 7
TH - Thailandia 7
NG - Nigeria 6
PL - Polonia 6
PT - Portogallo 6
FI - Finlandia 5
GH - Ghana 5
RS - Serbia 5
NO - Norvegia 4
SA - Arabia Saudita 4
CI - Costa d'Avorio 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
LT - Lituania 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BF - Burkina Faso 2
CL - Cile 2
DK - Danimarca 2
JO - Giordania 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
A1 - Anonimo 1
BG - Bulgaria 1
BZ - Belize 1
CO - Colombia 1
CU - Cuba 1
CY - Cipro 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
SI - Slovenia 1
SN - Senegal 1
TG - Togo 1
UG - Uganda 1
Totale 2.791
Città #
Ashburn 140
Turin 51
Nanjing 50
Houston 39
Shanghai 30
Jinan 29
Rome 28
Bedford 27
Beijing 27
Guangzhou 26
Shenyang 25
Wuhan 25
Garden Grove 24
Santa Cruz 24
Hyderabad 23
Hangzhou 20
Torino 20
Buffalo 19
Nanning 19
Milan 18
Ann Arbor 16
Dong Ket 16
Tacoma 16
Wilmington 16
Melbourne 15
Zhengzhou 15
Amsterdam 14
Bukhara 14
Central 14
Fairfield 14
Jakarta 14
Los Angeles 13
Newcastle upon Tyne 13
Boardman 12
Chengdu 12
Giza 11
Kolkata 11
Kuala Lumpur 11
London 11
New York 11
Pune 11
Bonn 10
Boston 10
Brooklyn 9
Chaoyang 9
Dublin 9
Frankfurt am Main 9
Seattle 9
Woodbridge 9
Cambridge 8
Council Bluffs 8
Istanbul 8
Moscow 8
Munich 8
Osaka 8
Seoul 8
Stockholm 8
Waltham 8
Bangkok 7
Bengaluru 7
Chicago 7
Fleming Island 7
Hefei 7
Ottawa 7
Sydney 7
Taipei 7
Tokyo 7
Florence 6
Parsippany 6
San Diego 6
San Francisco 6
Xian 6
Arlington 5
Central District 5
Curitiba 5
Delhi 5
Duncan 5
East Setauket 5
Hanoi 5
Kameino 5
Manchester 5
Memphis 5
Naples 5
Notre Dame 5
San Pablo City 5
Stalybridge 5
Vienna 5
Washington 5
Ankara 4
Atlanta 4
Bradford 4
Brescia 4
Charlestown 4
Chongqing 4
Dundee 4
Durham 4
Edirne 4
Genova 4
Helsinki 4
Kansas City 4
Totale 1.311
Nome #
Development of covalent NLRP3 inflammasome inhibitors: chemistry and biological activity, file e27ce42f-1c04-2581-e053-d805fe0acbaa 613
NEW NON-COVALENT INHIBITORS OF NLRP3 INFLAMMASOME ATPASE ACTIVITY, file e27ce42f-32eb-2581-e053-d805fe0acbaa 535
Covalent NLRP3 inhibitors: design strategies, synthesis and pharmacological characterization, file e27ce42f-1c0a-2581-e053-d805fe0acbaa 353
Inhibition of NLRP3 ATPase activity: a new strategy to fight chronic inflammatory diseases, file e27ce42f-0b4e-2581-e053-d805fe0acbaa 337
In silico study of NLRP3: towards selective inhibition with small molecules, file e27ce42f-1c08-2581-e053-d805fe0acbaa 298
Design and synthesis of encorafenib-based BRAF-V600E degraders, file d8e03593-a5c7-4f96-9d2b-d9bc3af47ed2 230
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold, file 08889351-65f4-45f0-9414-657c773f233e 169
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation, file e27ce42d-984c-2581-e053-d805fe0acbaa 141
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor, file e27ce432-3ce7-2581-e053-d805fe0acbaa 78
Targeting NLRP3 inflammasome: development of new covalent and non-covalent inhibitors of ATPase activity, file e27ce42e-c9c8-2581-e053-d805fe0acbaa 34
New inhibitors of NLRP3 inflammasome activation: pharmacological characterization in differentiated THP-1., file 954079b2-914e-412e-8988-c7d2bd09ec52 20
EVALUATION OF THE ANTIPYROPTOTIC ACTIVITY OF NEW INFLAMMASOME INHIBITORS, file e27ce434-886b-2581-e053-d805fe0acbaa 20
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation, file dbbf1cec-92cb-4b59-a79b-a1e7780a8780 19
Pharmacological characterization of new NLRP3 inflammasome inhibitors., file e27ce430-5aa6-2581-e053-d805fe0acbaa 17
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein, file d8cded6f-e57e-4e8c-87da-877e19c5510e 12
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO, file 37ad1cd5-fb55-4b64-b967-4a676c8a2a96 3
Development of covalent NLRP3 inflammasome inhibitors: chemistry and biological activity, file e27ce42f-1c05-2581-e053-d805fe0acbaa 2
Totale 2.881
Categoria #
all - tutte 4.908
article - articoli 0
book - libri 0
conference - conferenze 3.568
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 2 12 6
2019/2020513 5 3 6 1 0 79 95 62 62 65 90 45
2020/2021427 48 45 42 23 47 30 50 19 32 30 24 37
2021/2022652 46 35 153 45 44 27 45 43 70 41 58 45
2022/2023649 32 44 58 87 58 101 72 31 56 42 59 9
2023/2024610 46 60 54 57 42 81 91 169 10 0 0 0
Totale 2.881